CRAWLEY, England, April 23, 2014 /PRNewswire/ -- Elekta, a global medical technology company dedicated to oncology and neuroscience clinical advancements, has been awarded The Queen's Award for Enterprise in the International Trade category for the third consecutive year.

Elekta, with its UK headquarters in Crawley, has again won the country's highest accolade for business success. The award is presented each year by the Queen on the advice of the prime minister, who is assisted by an Advisory Committee that includes representatives of government, industry and commerce, and the trade unions.

The Queen's Award for International Trade acknowledges Elekta's third-consecutive year of continuous improvement in the company's overseas sales. Exports have more than doubled over the last six years.

Bill Yaeger, Elekta's Executive Vice President, Oncology, says: "We felt last year's second award was a historic moment. But to receive our third consecutive International Trade award – and sixth Queen's Award in total – is an exceptionally proud moment for the company.

"Crawley is where the life-changing digital linear accelerator first fulfilled its commercial destiny," Yaeger says.  "The management and staff here are committed to maintaining the intense pace of innovation that has made Elekta and Crawley renowned the world-over for excellence in radiotherapy."

The third consecutive Queen's Award confirmation follows last month's news of an investment in property adjacent to Elekta's Crawley office. This investment effectively demonstrates Elekta's commitment to Crawley and the region for many years to come.

This award is the latest in a series of accolades for Elekta this year. In March, Elekta won the award for Supply Chain Excellence at the prestigious annual Gatwick Diamond Business Awards 2014 in recognition of its engagement supporting local industry. Elekta also won the Made in the South East awards and an Institute of Export award.

For further information, please contact:

Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, e-mail: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.

SOURCE Elekta